FDA Direct - Special Edition of FDA Direct
Recapping a year's worth of progress, taking a moment to recognize our amazing staff, and discussing what's next for the FDA.
▶︎
FDA Direct: Combating Rare Diseases at the FDA
▶︎
FDA Direct: Who Buys the Spin — Hook, Line and Sinker?
▶︎
Advancing Real-Time Clinical Trials
▶︎
Adeno-Associated Virus-Mediated Gene Therapy - Advances, Immune Challenges, and Research Innovations
▶︎
Commissioner’s National Priority Voucher (CNPV) Pilot Program Public Hearing
▶︎
FDA Direct: What's the Deal with Talc? - Recapping
▶︎
FDA Direct: Dramatically lowering drug prices for Americans
▶︎
OTP Town Hall: Best Practices for Preparing BLA Submissions for Cell and Gene Therapy Products
▶︎
Understanding the Nutrition Facts Label, the Updated “Healthy” Claim, and Other Nutrition Claims
▶︎
FDA Direct: The Power of Real-Time Clinical Trials
▶︎
FDA Direct: These 9 Drugs Were Awarded National Priority Vouchers
▶︎
FDA Direct: Catching Up on Agency Reforms
▶︎
FDA Grand Rounds - Clinical Omics Biomarker Discovery and Validation in Precision Medicine
▶︎
FDA Direct: FDA is Not Your Doctor - Discussing FDA's Role and Mandate
▶︎
CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products
▶︎
FDA Direct: Faster Reviews, Food Dye Wins and Protecting American DNA
▶︎
VRBPAC -- May 28 Meeting
▶︎
FDA Direct: No One Think It's a Good Idea for Kids to Consume Petroleum Products
▶︎
FDA Direct, Striking a Balance - Framework for Future Covid-19 Vaccine Decisions
▶︎